
Bellicum Pharmaceuticals (BLCM) Earnings Dates & Reports
Bellicum Pharmaceuticals (BLCM) Most Recent Earnings
Report DateMar 31, 2023
Period EndingQ4 2022
Est. EPS-$0.93
Actual EPS-$0.20
EarningsBeat
Bellicum Pharmaceuticals (BLCM) Earnings
View the latest Bellicum Pharmaceuticals (BLCM) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Bellicum Pharmaceuticals (BLCM)
Order type
Buy in
Order amount
Est. shares
0 shares
Bellicum Pharmaceuticals (BLCM) Earnings per Share (EPS) History
Signup for full accessBrowse free
Bellicum Pharmaceuticals (BLCM) Latest Earnings
The value each BLCM share was expected to gain vs. the value each share gained.
Bellicum Pharmaceuticals (BLCM) reported its most recent earnings on Mar 31, 2023 for Q4 2022, posting earnings per share (EPS) of -$0.20. This exceeded analysts' expectations of -$0.93 by 78.49%, marking a Beat.
For comparison, Bellicum Pharmaceuticals reported EPS of $0.11 in the same quarter last year.
The company is expected to announce its next earnings report on 11/14/2023, with analysts projecting an EPS of $0.
Bellicum Pharmaceuticals (BLCM) Earnings History
Bellicum Pharmaceuticals (BLCM) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Bellicum Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 10, 2023 | — | — | — |
May 11, 2023 | — | — | — |
Mar 31, 2023 | — | — | — |
Nov 10, 2022 | — | — | — |
Bellicum Pharmaceuticals (BLCM) Earnings FAQs
Bellicum Pharmaceuticals (BLCM) last reported earnings on Mar 31, 2023 for Q4 2022, posting an EPS of -$0.20, which Beat the estimate of -$0.93 by 78.49%.
For Q4 2022, Bellicum Pharmaceuticals (BLCM) reported an EPS of -$0.20, exceeding analysts' estimate of -$0.93 by 78.49%.
For Q4 2022, Bellicum Pharmaceuticals (BLCM) Beat expectations with an actual EPS of -$0.20 vs. an estimated EPS of -$0.93.
Following the last earnings report on Mar 31, 2023, Bellicum Pharmaceuticals (BLCM)'s stock price moved — from — to —.
The next Bellicum Pharmaceuticals (BLCM) earnings call is scheduled for Nov. 14, 2023, where executives will discuss financial results and outlook.